Logo

Targan Secures Funding from Mountain Group Partners and NovaQuest Capital Management to Commercialize Poultry Vaccination and Gender Identification System

Share this
Targan Secures Funding from Mountain Group Partners and NovaQuest Capital Management to Commercialize Poultry Vaccination and Gender Identification System

Targan Secures Funding from Mountain Group Partners and NovaQuest Capital Management to Commercialize Poultry Vaccination and Gender Identification System

Shots:

  • Targan has completed $35M Series C equity financing for the commercialization of its automated & individualized poultry vaccination & gender identification system. The funding was co-led by Merck Animal Health & Oval Park Capital
  • The system developed by the company for the commercial poultry industry includes high-speed imaging, feature recognition, artificial intelligence, robotics & microfluidics. Targan has also developed a fully automated system to determine the gender of the chicks
  • This system can accurately vaccinate up to 100,000 chicks/hr against diseases incl. coccidiosis, infectious bronchitis & Newcastle disease

Ref: Businesswire | Image: Targan

Click here to­ read the full press release 

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions